Back to search
Childhood Astrocytoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Childhood Astrocytoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Childhood Astrocytoma trials you may qualify forThis phase I clinical trial studies the side effects and best dose of AZD1390 and to see how well it works when given together with radiation therapy for the tr…
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
This study is a clinical trial to determine the safety of inoculating G207 (an experimental virus therapy) into a recurrent or refractory cerebellar brain tumor…
Recent lab-based discoveries suggest that IDO (indoleamine 2,3-dioxygenase) and BTK (Bruton's tyrosine Kinase) form a closely linked metabolic checkpoint in tum…
This phase I/II trial studies the side effects and the best dose of selumetinib and how well it works in treating or re-treating young patients with low grade g…
Indoximod was developed to inhibit the IDO (indoleamine 2,3-dioxygenase) enzymatic pathway, which is important in the natural regulation of immune responses. Th…